STAT3 maintains a pro-carcinogenic inflammatory microenvironment during malignant transformation and cancer progression [32], and mediates the production of immunosuppressive cytokines in the TME, which is also a biomarker indicative of poor survival in TNBC [30, 33]. The gene discussed is STAT3; the disease is cancer.